A proteomic approach to understanding the development of multidrug-resistant Candida albicans strains

Molecular Genetics and Genomics

Volumn 271, Issue 5, 2004, Pages 554-565

  Kusch, H ^a,b   Biswas, K ^a   Schwanfelder, S ^a   Engelmann, S ^b   Rogers, P D ^c   Hecker, M ^b   Morschhauser J ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

^c Univ of TN Health Sciences Center   (United States)

Author keywords

Gene regulation; Multidrug efflux pumps; Proteomics; Regulatory networks; Two dimensional gel electrophoresis

Indexed keywords

FLUCONAZOLE; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2;

ANTIBIOTIC RESISTANCE; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; FUNGAL DEVELOPMENT; FUNGAL GENETICS; FUNGAL STRAIN; FUNGUS ISOLATION; GENE OVEREXPRESSION; GENETIC SUSCEPTIBILITY; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; REGULATOR GENE; REGULATORY MECHANISM; UPREGULATION;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; DRUG RESISTANCE, FUNGAL; DRUG RESISTANCE, MULTIPLE; FLUCONAZOLE; FUNGAL PROTEINS; GENE DELETION; GENE EXPRESSION; GENE EXPRESSION REGULATION, FUNGAL; OXIDATIVE STRESS; TRANSFORMATION, GENETIC;

CANDIDA; CANDIDA ALBICANS;

EID: 3142672919     PISSN: 16174615     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00438-004-0984-x     Document Type: Article

References (38)

1. Alarco AM, Raymond M (1999) The bZip transcription factor Cap1p is involved in multidrug resistance and oxidative stress response in Candida albicans. J Bacteriol 181:700-708
2. Ausubel F, Brent R, Kingston R, Moore D, Seidman J, Smith J, Struhl K (1989) Current protocols in molecular biology. Wiley, New York
3. Bernhardt J, Büttner K, Scharf C, Hecker M (1999) Dual channel imaging of two-dimensional electropherograms in Bacillus subtilis. Electrophoresis 20:2225-2240
4. Blum H, Beier H, Gross HJ (1987) Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels. Electrophoresis 8:93-99
5. Büttner K, Bernhardt J, Scharf C, Schmid R, Mader U, Eymann C, Antelmann H, Völker A, Völker U, Hecker M (2001) A comprehensive two-dimensional map of cytosolic proteins of Bacillus subtilis. Electrophoresis 22:2908-2935
6. Cowen LE, Nantel A, Whiteway MS, Thomas DY, Tessier DC, Kohn LM, Anderson JB (2002) Population genomics of drug resistance in Candida albicans. Proc Natl Acad Sci USA 99:9284-9289
7. De Micheli M, Bille J, Schueller C, Sanglard D (2002) A common drug-responsive element mediates the upregulation of the C andida albicans ABC transporters CDR1 and CDR2, two genes involved in antifungal drug resistance. Mol Microbiol 43:1197-1214
8. Fling ME, Kopf J, Tamarkin A, Gorman JA, Smith HA, Koltin Y (1991) Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methotrexate. Mol Gen Genet 227:318-329
9. Fonzi WA, Irwin MY (1993) Isogenic strain construction and gene mapping in Candida albicans. Genetics 134:717-728
10. Franz R, Kelly SL, Lamb DC, Kelly DE, Ruhnke M, Morschhäuser J (1998) Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains. Antimicrob Agents Chemother 42:3065-3072
11. Franz R, Ruhnke M, Morschhäuser J (1999) Molecular aspects of fluconazole resistance development in Candida albicans. Mycoses 42:453-458
12. Gauthier C, Weber S, Alarco AM, Alqawi O, Daoud R, Georges E, Raymond M (2003) Functional similarities and differences between Candida albicans Cdr1p and Cdr2p transporters. Antimicrob Agents Chemother 47:1543-1554
13. Gillum AM, Tsay EY, Kirsch DR (1984) Isolation of the Candida albicans gene for orotidine-5′-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol Gen Genet 198:179-182
14. Köhler GA, White TC, Agabian N (1997) Overexpression of a cloned IMP dehydrogenase gene of Candida albicans confers resistance to the specific inhibitor mycophenolic acid. J Bacteriol 179:2331-2338
15. Lopez-Ribot JL, McAtee RK, Lee LN, Kirkpatrick WR, White TC, Sanglard D, Patterson TF (1998) Distinct patterns of gene expression associated with development of fluconazole resistance in serial Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis. Antimicrob Agents Chemother 42:2932-2937
16. Millon L, Manteaux A, Reboux G, Drobacheff C, Monod M, Barale T, Michel-Briand Y (1994) Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: persistence of Candida albicans strains with the same genotype. J Clin Microbiol 32:1115-1118
17. Morschhäuser J (2002) The genetic basis of fluconazole resistance development in Candida albicans. Biochim Biophys Acta 1587:240-248
18. Morschhäuser J, Michel S, Hacker J (1998) Expression of a chromosomally integrated, single-copy GFP gene in Candida albicans, and its use as a reporter of gene regulation. Mol Gen Genet 257:412-420
19. Morschhäuser J, Michel S, Staib P (1999) Sequential gene disruption in Candida albicans by FLP-mediated site-specific recombination. Mol Microbiol 32:547-556
20. Nguyen D-T, Alarco AM, Raymond M (2000) Multiple Yap1p-binding sites mediate the induction of the yeast major facilitator FLR1 gene in response to drugs, oxidants, and alkylating agents. J Biol Chem 276:1138-1145
21. Odds FC (1988) Candida and candidosis: a review and bibliography. Bailliere Tindall, London
22. Perea S, Lopez-Ribot JL, Kirkpatrick WR, McAtee RK, Santillan RA, Martinez M, Calabrese D, Sanglard D, Patterson TF (2001) Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients. Antimicrob Agents Chemother 45:2676-2684
23. Prasad R, De Wergifosse P, Goffeau A, Balzi E (1995) Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr Genet 27:320-329
24. Rogers PD, Barker KS (2002) Evaluation of differential gene expression in fluconazole-susceptible and -resistant isolates of Candida albicans by cDNA microarray analysis. Antimicrob Agents Chemother 46:3412-3417
25. Rogers PD, Barker KS (2003) Genome-wide expression profile analysis reveals coordinately regulated genes associated with stepwise acquisition of azole resistance in Candida albicans clinical isolates. Antimicrob Agents Chemother 47:1220-1227
26. Ruhnke M, Eigler A, Tennagen I, Geiseler B, Engelmann E, Trautmann M (1994) Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. J Clin Microbiol 32:2092-2098
27. Sanglard D, Kuchler K, Ischer F, Pagani JL, Monod M, Bille J (1995) Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob Agents Chemother 39:2378-2386
28. Sanglard D, Ischer F, Monod M, Bille J (1996) Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors. Antimicrob Agents Chemother 40:2300-2305
29. Sanglard D, Ischer F, Monod M, Bille J (1997) Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. Microbiology 143:405-416
30. Sanglard D, Ischer F, Koymans L, Bille J (1998) Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents. Antimicrob Agents Chemother 42:241-253
31. Singleton DR, Masuoka J, Hazen KC (2001) Cloning and analysis of a Candida albicans gene that affects cell surface hydrophobicity. J Bacteriol 183:3582-3588
32. White TC (1997a) Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob Agents Chemother 41:1482-1487
33. White TC (1997b) The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14α demethylase in Candida albicans. Antimicrob Agents Chemother 41:1488-1494
34. White TC, Marr KA, Bowden RA (1998) Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 11:382-402
35. Wirsching S, Michel S, Köhler G, Morschhäuser J (2000a) Activation of the multiple drug resistance gene MDR1 in fluconazole-resistant, clinical Candida albicans strains is caused by mutations in a trans-regulatory factor. J Bacteriol 182:400-404
36. Wirsching S, Michel S, Morschhäuser J (2000b) Targeted gene disruption in Candida albicans wild-type strains: the role of the MDR1 gene in fluconazole resistance of clinical Candida albicans isolates. Mol Microbiol 36:856-865
37. Wirsching S, Moran GP, Sullivan DJ, Coleman DC, Morschhäuser J (2001) MDR1-mediated drug resistance in Candida dubliniensis. Antimicrob Agents Chemother 45:3416-3421
38. Zhang X, de Micheli M, Coleman ST, Sanglard D, Moye-Rowley WS (2000) Analysis of the oxidative stress regulation of the C andida albicans transcription factor Cap1p. Mol Microbiol 36:618-629